A platform for mRNA lipid nanoparticle delivery to the placenta to treat pre-eclampsia is shown to improve fetal and maternal health in mice and has potential clinical applications in obstetric disorders and women’s health.
- Kelsey L. Swingle
- Alex G. Hamilton
- Michael J. Mitchell